Martensen IP’s Chad G. Clark, along with ClearMark Founder Alison Sathe, will provide insights on how medical technology companies should use their intellectual property and regulatory strategies to advance internal innovation.
The U.S. government is highly dependent on Intellectual Property (IP), the vast majority of which sources from small and emerging companies. Average federal spending on IP tops $150 billion. But the rules for government-backed IP differ markedly from those in the commercial sector. And those rules are complex.